Good News Today Lunch Corona vaccine: Corona vaccine first approved in Russia and now China, first dose in India

Corona vaccine: Corona vaccine first approved in Russia and now China, first dose in India

Coronavirus vaccine latest update: Russia has started production of the Covid-19 vaccine Sputnik V after approval.  By the end of this month, the first batch will be in use.

After Russia's declaration of Coronavirus vaccine, the heat has intensified.  Given the potential of India's vaccine manufacturers, Russia has shown interest in the production of its Corona vaccine (Covid-19 vaccine) Sputnik V in India as well.  Kirill Dimitriv, CEO of the Russian Director Investment Fund, has said that talks are underway.  Russia has started the production of Corona vaccine.  She has said that the vaccine will be rolled out by the end of this month.  Regarding Sputnik V, many scientists say that Russia has ignored the procedure.

 China's first Kovid-19 vaccine 

China's first corona virus vaccine Ad5-nCoV has received a patent.  This vaccine has been created in collaboration with Major General Chen Wei of the Chinese Army and the CanSino Biologics Inc company.  According to the report of the Chinese government newspaper Global Times, this vaccine has received a patent.  China is trialing the third phase of this vaccine in many countries of the world and it is expected to hit the market by the end of this year. 

Russia has prepared the first batch of Kovid-19 vaccine Sputnik V.  This information was given by the Interfax News Agency, quoting the Ministry of Health.  Some scientists fear that Moscow has placed its reputation at stake by rapidly approving the vaccine.  Sputnik V is the first vaccine in the world to go into production and Russia has promised to make it available by the end of this month.  The vaccine usually gets approval after trials on thousands of people, but Russia has already cleared it.  The vaccine is named Sputnik V because the Soviet Union sent the world's first satellite to space with the same name.  President Vladimir Putin claims that the vaccine is completely safe and that one of his daughters has also been vaccinated.

The vaccine produced by Russia under the name Sputnik V can also be produced in India.  According to Kirill Dimitriv, CEO of the Russian Direct Investment Fund (RDIF), negotiations are on with Indian pharmaceutical producers.  RDIF has funded the research and production of vaccine.  It has been developed by the Gamalaya Research Institute of Epidemiology and Microbiology of Moscow.  Dimitriva said, "India and Russia have historically been partners in many sectors. RDIF has been associated with Indian companies since 2012."  He said that Russia has made a plan to produce 500 million doses every year in five countries.  Apart from India, there are talks with Korea and Brazil.

Russia claims that it affected all volunteers in the Phase-1 and Phase-2 trials of Sputnik V.  Within 21 days, the immunity developed.  According to Scientists, the immunity doubled when given a second injection of vaccine.  No serious side effects were seen on any volunteer.  Phase-3 trial of this vaccine will take place in Saudi Arabia, Philippines, Brazil and UAE, besides Russia.

भारतीय वैज्ञानिक भी कोरोना टीका बनाने में दिन-रात लगे हुए हैं। केंद्रीय स्‍वास्‍थ्‍य राज्‍य मंत्री अश्विनी कुमार चौबे का कहना है कि अगर वे कामयाब होते हैं तो कोविड-19 वॉरियर्स को सबसे पहले टीका लगेगा। उन्‍होंने कहा, "हमारे वैज्ञानिक इसपर बहुत मेहनत कर रहे हैं। कोविड-19 के खिलाफ तीन वैक्‍सीन टेस्टिंग के अलग-अलग स्‍टेज में हैं। और अगर हम वैक्‍सीन बनाने में सफल होते हैं तो हमारे कोविड वॉरियर्स को सबसे पहले डोज मिलेगी।"

Indian Council of Medical Research (ICMR) and Bharat Biotech's Covaxin and Zydus Cadila's ZyCov-D are undergoing trials on humans.  In addition, the Serum Institute of India has been approved for phase-2/3 trial of the University of Oxford-AstraZeneca vaccine.

American scientists have found the ability to stop the corona virus in a pre-existing drug through computer stimulation.  This drug prevents the cavid virus from replicating in host cells.  According to research published in the journal Science Advances, the chemical compound named Ebselen is equipped with many anti-viral, anti inflammatory, anti-oxidative, bactericidal and cell-protective properties.  Its use on humans has also been safe.  Now scientists will see the effect of this drug against Kovid-19.